Reply to letters on ethics of trials from bayesian perspective

BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7406.105 (Published 10 July 2003) Cite this as: BMJ 2003;327:105
  1. Richard J Lilford, professor of clinical epidemiology (r.j.lilford@bham.ac.uk)
  1. Department of Public Health and Epidemiology, Public Health Building, University of Birmingham, Birmingham B15 2TT

    EDITOR–In response to my paper Kunkler disagrees that telling people emphatically that “the best treatment is unknown” suppresses sophisticated questioning by the patient.1 2 But this was not my opinion: I was merely quoting what Donovan et al reported in their original paper.3 I was therefore pleased that instead of following Donovan et al's injunction to be unequivocal about uncertainty Hamdy et al give those …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription